Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Baxter
McKinsey
Covington
Cipla
Deloitte
Medtronic
Novartis

Generated: October 19, 2017

DrugPatentWatch Database Preview

SPECTRACEF Drug Profile

« Back to Dashboard

What is the patent landscape for Spectracef, and when can generic versions of Spectracef launch?

Spectracef is a drug marketed by Vansen Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has seventeen patent family members in fifteen countries.

The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefditoren pivoxil profile page.

Summary for Tradename: SPECTRACEF

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list26
Patent Applications: see list542
Drug Prices:see details
DailyMed Link:SPECTRACEF at DailyMed

Pharmacology for Tradename: SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001DISCNNoNo► Subscribe► Subscribe ► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: SPECTRACEF

Country Document Number Estimated Expiration
Portugal862915► Subscribe
Japan2831135► Subscribe
China1202110► Subscribe
Taiwan458778► Subscribe
Germany69620220► Subscribe
Argentina004014► Subscribe
Hong Kong1016477► Subscribe
China1102046► Subscribe
Brazil9610836► Subscribe
Hungary9900609► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Queensland Health
Johnson and Johnson
Merck
Daiichi Sankyo
Fuji
Cerilliant
Citi
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot